Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biolytica is a Swiss digital health company that developed software platforms for personalized health optimization and longevity-oriented preventive care. Its core offering, Biolytica NEXUS, aggregates and analyzes multimodal health data such as genomics, epigenetics, biomarkers, wearables, nutrition, lifestyle information, and questionnaires to help clinicians design individualized health plans. The company positioned itself as a B2B platform for prevention-focused clinicians and longevity professionals rather than as a therapeutics developer. Publicly available materials also reference Biolytica AIME as an additional product focused on predictive and human-centered health journey support. Although third-party business databases still describe the company as operating, Swiss registry sources indicate the legal entity is now in liquidation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biolytica.